Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200061843Phase 4Completed
Phase 4, randomised, open-label trial of quetiapine in schizophrenia (2 arms), sponsored by Beijing Anding Hospital. Primary endpoints: first-order false belief test, second-order false belief test and 3 more. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200061843.